Table 3.
Cost analysis of infected TKA and the case control group with reimbursements from the G-DRGs in Euro (€).
Group | Number of patients | Mean cost per patient | Mean reimbursement (G-DRGs) | Mean profit/loss | Cost coverage |
---|---|---|---|---|---|
Infected TKA | 28 | 25,194€ | 18,838€ | −6,356€ | 74.77% |
Case control group | 21 | 6,889€ | 7,816€ | +927€ | 111.86% |